DIRECT ALLERGY, LLC
ERIE, PA

Direct Allergy, LLC, headquartered in Erie, Pennsylvania, is a distinguished medical service organization specializing in on-site allergy and asthma testing along with customized immunotherapy treatments. Established by Robert Schultz, the Founder and President renowned for over 25 years of leadership across pharmaceutical and automotive industries, Direct Allergy offers an effective alternative to traditional over-the-counter medications by helping desensitize patients to allergens through its innovative treatments. Since its inception in 2013, Direct Allergy has expanded operations into seven states with a vision for rapid growth projected from 2018 to 2020. Financial and strategic endeavors have been supported by Ben Franklin Technology Partners, which played a critical role including an equity position acquired in 2015. The company was also recognized as the Best of Erie in 2015 and included Robert Schultz in Strathmore's 2017 Who’s Who. Complementing Schultz's leadership is Dr. Gruhlkey, President of the Pan American Allergy Society, who brings extensive expertise from his long-standing practice in Austin, TX, further bolstered by his academic achievements at Texas A&M University and UT Health Science Center – Houston. The team includes Joe Zajac, a seasoned executive with over 30 years in pharmaceuticals and data analytics who aids in formulating exceptional business models for the organization, as well as Mike Foss, an experienced business leader advising on financial management and strategic planning. Teresa Dugan contributes to human resources excellence following her tenure at The Pennsylvania State University's Ben Franklin Technology Partners network. Formed on June 19, 2017, under Florida corporate law, Direct Allergy is officially recognized with a filing number of M17000005293 as an organization limited liability (FORL) type. Located at 5340 Fryling Road, Suite 205 in Erie, PA and with operational numbers at (814) 899-2001 and (814) 899-2002, the company maintains a robust online presence via its website: directallergy.com. Its commitment to corporate responsibility and growth is evident through its recent annual report filed on April 29, 2024, for the year 2024 with a Federal Employer Identification Number of 461471853.